Skip to content

Clinical Evaluation of Balance Acupuncture for Short-Term Treatment of Chronic Coronary Syndrome (CCS) with Anxiety and/or Depression

Clinical Evaluation of Balance Acupuncture for Short-Term Treatment of Chronic Coronary Syndrome (CCS) with Anxiety and/or Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001756
Enrollment
Unknown
Registered
2026-07-16
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Coronary Syndrome

Interventions

Balance Acupuncture Group:Receive the same conventional medical therapy as the control group, plus Balance Acupuncture treatment as specified in the intervention protocol.
Control Group:Receive standard conventional medical therapy according to the 2024 ESC and 2024 Chinese guidelines for CCS, including secondary prevention medications (e.g., antiplatelet agents, antico

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18–75 years, any gender; (2) Diagnosed with CCS by both Western and TCM criteria; (3) Mild-to-moderate anxiety or depression (5 = GAD-7/PHQ-9 total score < 14); (4) Stable condition, good adherence, able to follow up; (5) No psychoactive medication use within the past month; (6) Willing to participate and sign informed consent (self or via legal guardian).

Exclusion criteria

Exclusion criteria: (1) Severe medical conditions: acute coronary syndrome, cardiogenic shock, malignant arrhythmia, high-grade AV block, obstructive cardiomyopathy, epilepsy, acute cerebrovascular disease, gastrointestinal bleeding, progressive severe infection, malignancy, hematological disease, severe liver/kidney dysfunction, etc.; (2) GAD-7 > 14 or PHQ-9 = 14; (3) Severe anxiety with mania requiring oral psychoactive medication; (4) History of psychosis, severe cognitive impairment, inability to communicate or cooperate; (5) Needle phobia, intolerance to acupuncture, or refusal to receive Balance Acupuncture; (6) Local skin lesions at acupuncture sites (e.g., scarring, ulceration, redness, swelling, or infection); (7) Currently participating in another clinical trial or receiving other treatments for this disease outside the protocol; (8) Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Generalized Anxiety Disorder 7-item scale (GAD-7);Patient Health Questionnaire-9 (PHQ-9);

Secondary

MeasureTime frame
Seattle Angina Questionnaire (SAQ-7);Traditional Chinese Medicine Syndrome Score Scale;hs-CRP;

Countries

China

Contacts

Public Contactzhouyuanshen

Guangdong Provincial Hospital of Chinese Medicine

13580347116@163.com13580347116

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026